Most firms sweating on product restructuring

A majority of Korean pharmaceutical companies are still struggling to finalize their product restructuring plans for the new year, according to pharmaceutical industry sources

The government’s large price cut plan has led many companies to say they have no choice but to sort out unprofitable products.

However, their restructuring plans are not favored by salespeople because their performa...